Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Here's Why You Should Add PODD Stock to Your Portfolio Now
07:11am, Thursday, 30'th Jan 2025
Insulet stays on investors' radar owing to its solid progress with Omnipod 5 and strong solvency position.
GEHC or PODD: Which Is the Better Value Stock Right Now?
12:41pm, Thursday, 16'th Jan 2025
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and Insulet (PODD). But which of these two stocks is more attractive to value investors?
PODD Stock Gains From the Launch of Omnipod 5 in Five Countries in EU
08:56am, Tuesday, 14'th Jan 2025
Insulet announces the launch of Omnipod 5 in five more countries in Europe, Italy, Denmark, Finland, Norway and Sweden.
Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe
04:01pm, Monday, 13'th Jan 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
06:00am, Friday, 10'th Jan 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
GEHC vs. PODD: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 31'st Dec 2024
Investors interested in stocks from the Medical - Products sector have probably already heard of GE HealthCare Technologies (GEHC) and Insulet (PODD). But which of these two companies is the best opti
Heavy Interest in Insulet's Insulin Delivery Device
03:47pm, Friday, 27'th Dec 2024
Sales are surging for Insulet Corporation (PODD).
Why Insulet (PODD) is a Top Momentum Stock for the Long-Term
10:56am, Friday, 13'th Dec 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
RMD or PODD: Which Is the Better Value Stock Right Now?
12:41pm, Thursday, 12'th Dec 2024
Investors interested in Medical - Products stocks are likely familiar with ResMed (RMD) and Insulet (PODD). But which of these two companies is the best option for those looking for undervalued stocks
Should You Continue to Retain Insulet Stock in Your Portfolio Now?
08:26am, Monday, 09'th Dec 2024
PODD stock stays on investors' radar owing to its solid progress with Omnipod 5 and robust potential in the diabetes market.
Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case
11:05am, Thursday, 05'th Dec 2024
Medical device maker Insulet convinced a jury that Korean rival EOFlow owes it $452 million in damages for stealing trade secrets related to insulin pumps, according to a verdict made public in Massac
Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court
04:28pm, Wednesday, 04'th Dec 2024
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced that i
Here's Why Insulet (PODD) is a Strong Growth Stock
10:50am, Friday, 29'th Nov 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US
11:15am, Friday, 22'nd Nov 2024
Insulet's Omnipod 5 System is now compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the United States.
Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines
06:26pm, Wednesday, 20'th Nov 2024
Insulet's stock has surged over 50% in six months due to strong Q3 earnings and expanded market potential with Omnipod 5's approval for Type 2 diabetes. Despite impressive growth, high market expectat
